Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 16,275 | 8,141 | N/A | N/A | N/A |
| Income taxes - deferred | -1,668 | -889 | 1,564 | 0 | 3 |
| Accounts receivable | 7,629 | 12,505 | -10,844 | -4 | -121 |
| Accounts payable and accrued liabilities | -1,259 | -1,367 | N/A | N/A | N/A |
| Other Working Capital | 4,810 | 9,416 | -8,073 | 134 | -351 |
| Other Operating Activity | -10,600 | -14,306 | 45,665 | -156 | -183 |
| Operating Cash Flow | $15,187 | $13,500 | $28,311 | $-25 | $-652 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -90 | -24 | -179 | 0 | 0 |
| Net Acquisitions | -6,650 | -4,325 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -212 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | -10,535 | 74 | 56 |
| Investing Cash Flow | $-6,952 | $-4,349 | $-10,714 | $74 | $56 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -13,381 | -7,104 | N/A | N/A | N/A |
| Common Stock Issued | 19,470 | 19,470 | N/A | N/A | N/A |
| Common Stock Repurchased | -238 | N/A | N/A | -7 | 0 |
| Other Financing Activity | -4,436 | -3,688 | -18,203 | 0 | 0 |
| Financing Cash Flow | $1,415 | $8,678 | $-18,203 | $-7 | $0 |
| Exchange Rate Effect | -632 | -223 | N/A | N/A | N/A |
| Beginning Cash Position | 36,219 | 36,219 | 26,274 | 24,975 | 24,928 |
| End Cash Position | 45,237 | 53,825 | 36,219 | 26,274 | 24,975 |
| Net Cash Flow | $9,650 | $17,829 | $-606 | $41 | $-596 |
| Free Cash Flow | |||||
| Operating Cash Flow | 15,187 | 13,500 | 28,311 | -25 | -652 |
| Capital Expenditure | -302 | -24 | N/A | N/A | N/A |
| Free Cash Flow | 14,885 | 13,476 | 28,311 | -25 | -652 |